// App-Quantinova.ai

17 : Global Treatment Satisfaction Levels and Treatment Patterns from the International Sickle Cell World Assessment Survey (SWAY): Hydroxyurea (HU) Versus No HU

Researchers

Presenter

  • Fuad A El Rassi

Principal Investigators

  • Biree Andemariam

  • Baba PD Inusa

  • Beverley Francis-Gibson

  • Alecia C Nero

  • Caterina P. Minniti

  • Cassandra Trimnell

  • Miguel R Abboud

  • Jean-Benot Arlet

  • Raffaella Colombatti

  • Mariane de Montalembert

  • Suman Jain

  • Wasil Jastaniah

  • Erfan Nur

  • Marimilia Pita

  • Nicholas Ramscar

  • Tom Bailey

  • Olivera Rajkovic-Hooley

  • Ifeyinwa Osunkwo

Medical Centers

  • Emory University School of Medicine and Georgia Comprehensive Sickle Cell Center at Grady Health System,Atlanta, GA,United States

  • Sickle Cell Society, London, United Kingdom

  • New England Sickle Cell Institute at the University of Connecticut, Farmington, CT

  • Evelina Childrens Hospital / Guys and St Thomas Hospitals, London, United Kingdom

  • Sickle Cell Disease Association of America, Baltimore, MD

  • The University of Texas Southwestern Medical Center, Dallas, TX

  • Albert Einstein College of Medicine, Great Neck, NY

  • Sickle Cell 101,San Jose,USA

  • Hopital European Georges Pompidou, Paris, France

  • Azienda Ospedaliera di Padova, Padova, Italy

  • AP-HP Hopital Universitaire Necker Enfants Malades, Paris, France

  • Thalassemia And Sickle Cell Society,Hyderabad,Indien

  • Umm Al-Qura University, Mecca, Saudi Arabia

  • Academic Medical Center, Amsterdam, Netherlands

  • Laureate University-UAM, Pediatric-Hematology, Hospital Samaritano, São Paulo, Brazil

  • Novartis AG, Basel, Switzerland

  • Adelphi Real World, Bollington, United Kingdom

  • Sickle Cell Disease Enterprise at The Levine Cancer Institute/Atrium Health,Charlotte,United States

Locations

  • United States

  • United Kingdom

  • Lebanon

  • France

  • Italy

  • India

  • Saudi Arabia

  • Netherlands

  • Brazil

  • Switzerland

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Stearoyl-CoA desaturase

Drug/Treatment

  • Hydroxyurea

  • Hydroxycarbamide

Outcome

  • N/A

Study Design

  • Multinational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved